ArticleFrontiers in oncology2025

CAR T- cell therapy provides an opportunity for further consolidation treatment for relapsed or refractory adult Burkitt lymphoma patients.

Rui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.